MondayAug 08, 2022 11:24 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reports Second Quarter 2022 Results

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, has filed its Q2 2022 financial results for the period ended June 30, 2022; the company also scheduled a webcast to discuss those results. The webcast is slated for Aug. 9, 2022, at 4 p.m. EDT. Highlights of the report show that Energy Fuels has a robust balance sheet with $134.1 million of working capital; total includes $86.4 million in cash and cash equivalents, $11.8 million marketable securities and $28.6 million of inventory with no debt; the report noted that at current commodity prices, the company's product inventory has a…

Continue Reading

WednesdayAug 03, 2022 3:33 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Records First $9M Quarter

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced it recorded record revenues exceeding $9 million in the third fiscal quarter ended July 31, 2022. According to the update, this represents an estimated 177% improvement on revenues of $3.25 million in the comparable year-ago quarter. “We are excited by meaningful progress and growth in both our B2B and B2C divisions,” said Golden Matrix CEO Brian Goodman. “The company has now recorded its first $9 million quarter, which is even more impressive when considering the impact of global economic headwinds and an…

Continue Reading

WednesdayAug 03, 2022 2:35 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

Continue Reading

WednesdayAug 03, 2022 1:51 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces Significant Expansion of Service to PG&E, Utility Company Doubles Number of ASRs under Contract

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to expand its footprint as new clients sign up for the K5 Autonomous Security Robots (“ASRs”) and existing clients add to their contracts. The most recently announced growth comes as the Pacific Gas and Electric Company (“PG&E”), the leading subsidiary of the holding company PG&E Corporation (NYSE: PCG), has ordered an additional five ASRs. PG&E has now contracted with Knightscope for 10 robots, which provide the levels of safety and overwatch necessary to secure the client’s properties. According to the announcement, PG&E first…

Continue Reading

WednesdayAug 03, 2022 10:27 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Adds EV Technology Team Centrally Located to Motor City Resources

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the addition of a new EV Technology team, focusing on developing EV technologies for Mullen’s portfolio of commercial vans. Located in Pontiac, Michigan, and centrally located to all automotive resources the Motor City Area has to offer, the team will be home to a new division of engineers and technology developers focused on Mullen’s Class 1 – 5 commercial vehicle development. The “Detroit Tech Center” and its team will play a critical role in Mullen’s goal of developing highly efficient EV technology that utilizes less energy consumption while…

Continue Reading

TuesdayAug 02, 2022 1:50 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. “DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a…

Continue Reading

TuesdayAug 02, 2022 12:40 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Spotlighted in Benzinga Live Interview

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, will be the topic of discussion in an upcoming Benzinga YouTube channel interview. The live interview, hosted by Zunaid Sulemanet and slated for Aug. 4, 2022, at 1:30 p.m. ET will feature Mullen CEO and chair David Michery. According to the announcement, Michery’s previous interviews with Benzinga have been some of its most popular events, with viewers from around the world watching the live one-on-one discussions. “I look forward to connecting with Benzinga later this week, especially after a recent health event that kept me away from the office for…

Continue Reading

TuesdayAug 02, 2022 12:20 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast

Aditxt (NASDAQ: ADTX) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Amro Albanna, co-founder, chairman and CEO of Aditxt, joined the latest episode to provide an overview of the company and discuss its business model. “We are a biotech innovation company, and our focus is on immune diseases. The reality is that immune diseases are caused either by someone having too little immune response or too much immune response,” Albanna said. “When you have too little immune response and you’re dealing with COVID-19, we all understand…

Continue Reading

TuesdayAug 02, 2022 11:37 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Joint Venture with Colombia’s Largest Indigenous Tribe

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced a joint venture agreement with Pharma Indigena Misak Manasr Sas (“Manasr”), the largest indigenous tribe in Colombia, on the development of cultivation best practices, manufacturing, export, and marketing of cannabis and cannabis containing products. “We are honored to be given opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s chairman and CEO. “Through this partnership, we will collaborate with the tribe on the processing and distribution of their Colombian-grown cannabis while offering Manasr a powerful platform…

Continue Reading

MondayAug 01, 2022 11:16 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Names Industry Veteran as New COO

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence across automotive and smart infrastructure markets. Han joined Cepton in 2016 and has served as both vice president and senior vice president of operations, where he has led product development, commercialization and operational excellence teams;…

Continue Reading

Contact us: (512) 354-7000